Works by Lewis, Lionel D.
Results: 60
Pevonedistat, a Nedd8-activating enzyme inhibitor, in combination with ibrutinib in patients with relapsed/refractory B-cell non-Hodgkin lymphoma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-022-00763-w
- By:
- Publication type:
- Article
Delayed neurological sequelae from ethylene glycol, diethylene glycol and methanol poisonings.
- Published in:
- Clinical Toxicology (15563650), 2010, v. 48, n. 10, p. 967, doi. 10.3109/15563650.2010.532803
- By:
- Publication type:
- Article
A phase II study of alternating sunitinib and temsirolimus therapy in patients with metastatic renal cell carcinoma.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 12, p. 13100, doi. 10.1002/cam4.5990
- By:
- Publication type:
- Article
A phase I dose-ranging study of bendamustine and rituximab in chronic lymphocytic leukemia patients with comorbidities.
- Published in:
- British Journal of Haematology, 2017, v. 178, n. 5, p. 820, doi. 10.1111/bjh.14171
- By:
- Publication type:
- Article
Agranulocytosis Associated with Lamotrigine in a Patient with Low-grade Glioma.
- Published in:
- Epilepsia (Series 4), 2002, v. 43, n. 2, p. 199, doi. 10.1046/j.1528-1157.2002.31801.x
- By:
- Publication type:
- Article
Phase I study to assess the effect of adavosertib (AZD1775) on the pharmacokinetics of substrates of CYP1A2, CYP2C19, and CYP3A in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 3, p. 193, doi. 10.1007/s00280-023-04554-3
- By:
- Publication type:
- Article
Adavosertib (AZD1775) does not prolong the QTc interval in patients with advanced solid tumors: a phase I open-label study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 2, p. 141, doi. 10.1007/s00280-023-04555-2
- By:
- Publication type:
- Article
Potential Impact of Pharmacogenomic Single Nucleotide Variants in a Rural Caucasian Population.
- Published in:
- Journal of Applied Laboratory Medicine, 2023, v. 8, n. 2, p. 251, doi. 10.1093/jalm/jfac091
- By:
- Publication type:
- Article
Clinical Validation of a 106-SNV MALDI-ToF MS Pharmacogenomic Panel.
- Published in:
- Journal of Applied Laboratory Medicine, 2020, v. 5, n. 3, p. 454, doi. 10.1093/jalm/jfaa018
- By:
- Publication type:
- Article
Clinical and research updates on the VISTA immune checkpoint: immuno-oncology themes and highlights.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1225081
- By:
- Publication type:
- Article
Editors' report, November 2011.
- Published in:
- British Journal of Clinical Pharmacology, 2012, v. 73, n. 2, p. 159, doi. 10.1111/j.1365-2125.2011.04148.x
- By:
- Publication type:
- Article
Editors' pick 2011.
- Published in:
- British Journal of Clinical Pharmacology, 2012, v. 73, n. 1, p. 4, doi. 10.1111/j.1365-2125.2011.04144.x
- By:
- Publication type:
- Article
Editors' report, November 2010.
- Published in:
- 2011
- By:
- Publication type:
- Editorial
Editors' pick 2010.
- Published in:
- 2011
- By:
- Publication type:
- Editorial
Early human studies of investigational agents: dose or microdose?
- Published in:
- 2009
- By:
- Publication type:
- Editorial
Editors' Report for 2006.
- Published in:
- 2007
- By:
- Publication type:
- Other
Editors’ review of 2006 and the BJCP prize.
- Published in:
- 2007
- By:
- Publication type:
- Other
Editors’ Report 2005.
- Published in:
- 2006
- By:
- Publication type:
- Editorial
Today's science, tomorrow's medicines.
- Published in:
- 2006
- By:
- Publication type:
- Editorial
Personalized drug therapy; the genome, the chip and the physician.
- Published in:
- 2005
- By:
- Publication type:
- Editorial
Drug Delivery Systems in Cancer Therapy.
- Published in:
- 2004
- By:
- Publication type:
- Book Review
A study of 5 day fractionated ifosfamide pharmacokinetics in consecutive treatment cycles.
- Published in:
- British Journal of Clinical Pharmacology, 1996, v. 42, n. 2, p. 179, doi. 10.1046/j.1365-2125.1996.03956.x
- By:
- Publication type:
- Article
Tumor Cell Targeting by Iron Oxide Nanoparticles Is Dominated by Different Factors In Vitro versus In Vivo.
- Published in:
- PLoS ONE, 2015, v. 10, n. 2, p. 1, doi. 10.1371/journal.pone.0115636
- By:
- Publication type:
- Article
Standing in the Shifting Sands of Molecular Targeting and Precision Medicine Is the Oasis of 21st-Century Oncology Therapeutics.
- Published in:
- Journal of Clinical Pharmacology, 2017, v. 57, p. S7, doi. 10.1002/jcph.1011
- By:
- Publication type:
- Article
Clinical trial simulation to evaluate population pharmacokinetics and food effect: Capturing abiraterone and nilotinib exposures.
- Published in:
- Journal of Clinical Pharmacology, 2015, v. 55, n. 5, p. 556, doi. 10.1002/jcph.449
- By:
- Publication type:
- Article
1998 ASCPT workshop on Clinical Pharmacology in Primary Care Residency Education.
- Published in:
- Clinical Pharmacology & Therapeutics, 1997, v. 62, n. 6, p. 694, doi. 10.1016/S0009-9236(97)90091-6
- By:
- Publication type:
- Article
Olsalazine and 6-mercaptopurine-related bone marrow suppression: A possible drug-drug interaction.
- Published in:
- Clinical Pharmacology & Therapeutics, 1997, v. 62, n. 4, p. 464, doi. 10.1016/S0009-9236(97)90125-9
- By:
- Publication type:
- Article
Delayed sequelae after acute overdoses or poisonings: Cranial neuropathy related to ethylene glycol ingestion.
- Published in:
- Clinical Pharmacology & Therapeutics, 1997, v. 61, n. 6, p. 692, doi. 10.1016/S0009-9236(97)90105-3
- By:
- Publication type:
- Article
Tumor pharmacokinetics and pharmacodynamics of the CDK4/6 inhibitor ribociclib in patients with recurrent glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2019, v. 144, n. 3, p. 563, doi. 10.1007/s11060-019-03258-0
- By:
- Publication type:
- Article
A phase I trial of BNC105P and ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia.
- Published in:
- EJHaem, 2022, v. 3, n. 4, p. 1445, doi. 10.1002/jha2.543
- By:
- Publication type:
- Article
Stealth Liposomes Encapsulating a Potent ACAT1/SOAT1 Inhibitor F12511: Pharmacokinetic, Biodistribution, and Toxicity Studies in Wild-Type Mice and Efficacy Studies in Triple Transgenic Alzheimer's Disease Mice.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 13, p. 11013, doi. 10.3390/ijms241311013
- By:
- Publication type:
- Article
A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumors.
- Published in:
- BMC Cancer, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2407-13-20
- By:
- Publication type:
- Article
A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumors.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Kynurenine-Induced Aryl Hydrocarbon Receptor Signaling in Mice Causes Body Mass Gain, Liver Steatosis, and Hyperglycemia.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Establishment of a CYP2C19 Genotyping Assay for Clinical Use.
- Published in:
- American Journal of Clinical Pathology, 2013, v. 139, n. 2, p. 202, doi. 10.1309/AJCP9K2KDOCPCBSV
- By:
- Publication type:
- Article
The effects of lapatinib on cardiac repolarization: results from a placebo controlled, single sequence, crossover study in patients with advanced solid tumors.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The effects of lapatinib on CYP3A metabolism of midazolam in patients with advanced cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Pharmacokinetics and safety of vismodegib in patients with advanced solid malignancies and hepatic impairment.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The pharmacokinetics of the bispecific antibody MDX-H210 when combined with interferon gamma-1b in a multiple-dose phase I study in patients with advanced cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2002, v. 49, n. 5, p. 375, doi. 10.1007/s00280-002-0424-8
- By:
- Publication type:
- Article
Tumour, whole‐blood, plasma and tissue concentrations of metformin in lung cancer patients.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 3, p. 1027, doi. 10.1111/bcp.15546
- By:
- Publication type:
- Article
Spotlight commentary: Navigating between financial risks and improved treatment outcomes with immune checkpoint inhibitors in cancer patients: The need for biomarker identification and dose optimization.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 12, p. 5060, doi. 10.1111/bcp.15548
- By:
- Publication type:
- Article
Medicamenta ad sentinam, et defectum vitae: Drugs and failure of the pump of life‐cardiotoxicity of oncotherapeutics.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 3, p. 735, doi. 10.1111/bcp.14558
- By:
- Publication type:
- Article
The effect of sonidegib (LDE225) on the pharmacokinetics of bupropion and warfarin in patients with advanced solid tumours.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 3, p. 1291, doi. 10.1111/bcp.14508
- By:
- Publication type:
- Article
Taking the brake off the immune system: Hypotheses, trials, tribulations, and the evolving discipline of clinical immunopharmacology.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1674, doi. 10.1111/bcp.14481
- By:
- Publication type:
- Article
Effect of ketoconazole, a strong CYP3A inhibitor, on the pharmacokinetics of venetoclax, a BCL-2 inhibitor, in patients with non-Hodgkin lymphoma.
- Published in:
- British Journal of Clinical Pharmacology, 2017, v. 83, n. 4, p. 846, doi. 10.1111/bcp.13175
- By:
- Publication type:
- Article
Vincristine activates c-Jun N-terminal kinase in chronic lymphocytic leukaemia in vivo.
- Published in:
- British Journal of Clinical Pharmacology, 2015, v. 80, n. 3, p. 493, doi. 10.1111/bcp.12624
- By:
- Publication type:
- Article
Pharmacodynamics and pharmacokinetics of oral topotecan in patients with advanced solid tumours and impaired renal function.
- Published in:
- British Journal of Clinical Pharmacology, 2015, v. 80, n. 2, p. 253, doi. 10.1111/bcp.12606
- By:
- Publication type:
- Article
Vatalanib population pharmacokinetics in patients with myelodysplastic syndrome: CALGB 10105 (Alliance).
- Published in:
- British Journal of Clinical Pharmacology, 2014, v. 78, n. 5, p. 1005, doi. 10.1111/bcp.12427
- By:
- Publication type:
- Article
Editors' report, November 2013.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
Editors' pick 2013.
- Published in:
- British Journal of Clinical Pharmacology, 2014, v. 77, n. 2, p. 228, doi. 10.1111/bcp.12303
- By:
- Publication type:
- Article